Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Trojano

Showing results (11-20 of 342) with videos related to

Pageof 35
Sort By:
European Neurology|October 13, 2016
Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily PracticePatrick Vermersch, Maria Trojano
Nature Reviews. Neurology|February 26, 2021
Assessing long-term effectiveness of MS treatment - a matter of debateMaria Trojano, Pietro Iaffaldano
Journal of Neurology, Neurosurgery, and Psychiatry|April 18, 2009
Epstein-Barr virus (EBV) and multiple sclerosis association: EBV has a primary or secondary role?Maria Trojano, Carlo Avolio
The Lancet Regional Health. Europe|July 3, 2025
Targeting smouldering neuroinflammation in multiple sclerosis: insights from tolebrutinib clinical trialsMaria Trojano, Damiano Paolicelli
Current Opinion in Neurology|April 2, 2026
Big data in multiple sclerosisMaria Trojano, Pietro Iaffaldano
Nature Reviews. Neurology|February 1, 2018
Multiple sclerosis in 2017: Progress in multiple sclerosis - from diagnosis to therapyMaria Trojano, Maria Pia Amato
Nature Reviews. Neurology|April 3, 2019
Author Correction: Progress in multiple sclerosis - from diagnosis to therapyMaria Trojano, Maria Pia Amato
Journal of Neuroimmunology|September 3, 2004
Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from Multiple Sclerosis patientsMaurizio Giorelli, Paolo Livrea, Maria Trojano
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 19, 2005
Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-betaMaurizio Giorelli, Paolo Livrea, Maria Trojano
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 15, 2018
Natalizumab reduces serum pro-angiogenic activity in MS patientsPietro Iaffaldano, Domenico Ribatti, Maria Trojano
Pageof 35

Showing results (11-20 of 342) with videos related to

Sort By:
Pageof 35
European Neurology|October 13, 2016
Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily PracticePatrick Vermersch, Maria Trojano
Nature Reviews. Neurology|February 26, 2021
Assessing long-term effectiveness of MS treatment - a matter of debateMaria Trojano, Pietro Iaffaldano
Journal of Neurology, Neurosurgery, and Psychiatry|April 18, 2009
Epstein-Barr virus (EBV) and multiple sclerosis association: EBV has a primary or secondary role?Maria Trojano, Carlo Avolio
The Lancet Regional Health. Europe|July 3, 2025
Targeting smouldering neuroinflammation in multiple sclerosis: insights from tolebrutinib clinical trialsMaria Trojano, Damiano Paolicelli
Current Opinion in Neurology|April 2, 2026
Big data in multiple sclerosisMaria Trojano, Pietro Iaffaldano
Nature Reviews. Neurology|February 1, 2018
Multiple sclerosis in 2017: Progress in multiple sclerosis - from diagnosis to therapyMaria Trojano, Maria Pia Amato
Nature Reviews. Neurology|April 3, 2019
Author Correction: Progress in multiple sclerosis - from diagnosis to therapyMaria Trojano, Maria Pia Amato
Journal of Neuroimmunology|September 3, 2004
Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from Multiple Sclerosis patientsMaurizio Giorelli, Paolo Livrea, Maria Trojano
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 19, 2005
Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-betaMaurizio Giorelli, Paolo Livrea, Maria Trojano
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 15, 2018
Natalizumab reduces serum pro-angiogenic activity in MS patientsPietro Iaffaldano, Domenico Ribatti, Maria Trojano
Pageof 35